Anti-LGI1 encephalitis recurring 3 years after the first episode: a case report

BACKGROUND: Patients with antibodies against leucine-rich glioma-inactivated 1 (LGI1) present with limbic encephalitis, which is clinically characterized by a subacute disturbance of memory and behavior, often experience seizures. Most patients have a monophasic course, often with hyponatremia. CASE...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Hiroaki, Shioda, Mukuto, Suzuki, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022306/
https://www.ncbi.nlm.nih.gov/pubmed/35448972
http://dx.doi.org/10.1186/s12883-022-02674-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022306/
https://www.ncbi.nlm.nih.gov/pubmed/35448972
http://dx.doi.org/10.1186/s12883-022-02674-6

Ejemplares similares